Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-001600

Chief Financial Officer gave up 10,553 shares (to pay taxes)

  • Chief Financial Officer acquired 18,850 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bellemin Jean-Marc · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-03 Exercise or conversion : show line 1 in the form +18,850 28,354 D
2023-01-03 Shares withheld for taxes : show line 2 in the form −10,553 $6.11 $64,479 17,801 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −18,850 0 D
Loading xslF345X03/tm232380d1_4seq1.xml…